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The glomerular mesangium in diabetes mellitus
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The glomerular mesangium in diabetes mellitus. Like the renal gb-
merular mesangium in patients with diabetic nephropathy, glomerular
mesangial cell cultures grown in 30 m glucose accumulate increased
amounts of the extracellular matrix (ECM) proteins fibronectin, lami-
nm, and type IV collagen. This is due to increased ECM protein
synthesis and mRNA levels. Similar to other cells types that are
affected by the diabetic state (such as, vascular cells and peripheral
nerve), mesangial cells transport glucose by an insulin-independent,
facilitated diffusion transport system. Kinetic studies reveal that intra-
cellular glucose levels may reach the ambient glucose concentrations
achieved in diabetes. Growth studies reveal that glucose does not exert
its effect on mesangial cell ECM accumulation by affecting cell growth,
but rather it causes an increase in diacylglycerol (DAG) mass and
activates protein kinase C. Agents such as phorbol myristate acetate
(PMA) and the cell permeable DAG analogue, oleoyl acetyl glycerol
(OAG) which activate protein kinase C also increase ECM mRNAs.
These results implicate protein kinase C activation in the increased
ECM accumulation observed in mesangial cell cultures grown in high
glucose.
Strong evidence exists in both animals and humans that
hyperglycemia contributes significantly to diabetic microangi-
opathy E1—31. For example, diabetic glomerulopathy is signifi-
cantly less severe in diabetic patients who received a successful
pancreatic transplant after a renal allograft [4]. Also, the degree
of mesangial expansion in diabetic rats receiving a pancreatic
transplant is similarly ameliorated [5]. In the renal glomerulus,
intercapillary glomeruloscierosis or Kimmelstiel-Wilson nod-
ules composed of increased amounts of extracellular matrix
(ECM) proteins [6—8] is the structural lesion most closely
associated with the clinical manifestations of diabetic nephrop-
athy (that is, declining GFR, proteinuria, and hypertension) [9,
10]. Although hyperglycemia plays a significant role in the
development of diabetic glomerulopathy, the mechanisms by
which it exerts its damaging effect is unknown.
With the development of techniques to culture homogeneous
populations of glomerular mesangial cells, it is now possible to
examine the role high glucose plays in ECM metabolism. It
appears that growth in 30 m glucose causes mesangial cells to
synthesize increased amounts of ECM proteins by increasing
the DAG content of the cells and activating protein kinase C
[11—13]. Protein kinase C is a ubiquitous enzyme that is acti-
vated by DAG. It is involved in transducing extracellular
signals received by cells from a wide variety of substances such
as growth factors and hormones into physiological responses
[14—16].
Methods
Mesangial cell culture
Rat mesangial cells were isolated and grown in homogeneous
culture as previously described by us [11—13]. Cells were
cultured in RPM! 1640 tissue culture medium supplemented
with 20% fetal calf serum (FCS) (Irvine Scientific, Irvine,
California, USA) plus antibiotics and antimycotics. Cells were
used between the 20th and 40th passages. At these passages
mesangial cells isotonically contracted in response to arginine
vasopressin when plated onto slippery substrata [17].
To determine the effect of high glucose on mesangial cell
growth and ECM metabolism, cells were grown for varying
periods under control (10 mM) and high (30 mM) glucose
conditions. The concentration of insulin in the FCS was mea-
sured by radioimmunassay (Smith Kline BioScience Laborato-
ries, Houston, Texas, USA) and found to be in the range
reported for streptozotocin diabetic rats (6 U/ml) [8]. Al-
though 10 m glucose is high compared to normal serum
glucose, this is the amount necessary for rat mesangial cells to
grow well in culture (J.I. Kreisberg, personal observation).
Cell growth studies
To study the effect of 30 m glucose on mesangial cell
growth, mesangial cells were plated in 6-well (35 mm) (Corning
Corp., Corning, New York, USA) dishes in RPM! 1640 plus
20% FCS (containing 10 m glucose). Twenty-four hours later,
the cells were rinsed three times in RPM! without FCS and
made quiescent by serum depletion for 72 hours (RPMI 1640 +
0.4% FCS). After 72 hours, the medium was changed to RPM!
1640 with 20% FCS containing either 10 or 30 m glucose. Cells
were counted at 0 time and one, two, four, and seven days after
media change. Counts were done on six wells of cells under
each condition.
Hexose uptake studies
Cell monolayers in 6-well multiwell dishes (Corning) were
rinsed three times with RPM! 1640 without glucose and incu-
bated for one hour in serum-free, glucose-free RPM!. Deoxy-
D-glucose,2- [3H] (Dupont, New England Nuclear, Wilmington,
Delaware, USA) (3H-2-deoxyglucose) (10 tCi/ml) was then
added at specific concentrations in a total volume of 1 ml and
the incubation continued for four hours at 37°C. Velocity was
linear out to eight hours. Insulin (0.7 iM) was added during the
incubation to determine its effect on glucose transport. Cellular
uptake was determined by aspirating the radioactive incubation© 1993 by the International Society of Nephrology
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Fig. 1. Effect of high glucose on mesangial cell growth. Cells were
plated in normal RPMI 1640 (containing 10 mM glucose), made quies-
cent and the conditions were changed to complete media containing
either 10 m or 30 m.i glucose. Fig. 2. Effect of external substrate concentration on rate of 3H-2-
deoxyglucose uptake in confluent mesangial cell monolayers. Data
represent the average of six determinations.
Table 1. Effect of insulin on glucose transport
Condition
Glucose transport
cpm/103 cells
10 m glucose 4621 399
10 mM plus insulin 4437 397
medium and then rapidly washing with cold PBS. The mono-
layer was dissolved in 1% sodium dodecyl sulfate and counted
by scintillation spectroscopy. Six well of cells were examined at
each glucose concentration.
Results
Mesangial cells exposed to growth medium containing 30 mM
glucose showed no alterations in their growth properties com-
pared to cells grown in medium containing 10 mrvi glucose (Fig.
1).
Insulin has no effect on glucose transport by mesangial cells
(Table 1). Rather, the data indicate that glucose is transported
by facilitated diffusion (Figs. 2 and 3). Saturation of 2-deoxy-
glucose uptake occurs at a substrate concentration of 30 to 35
m (Fig. 2). A double reciprocal plot of the uptake data reveals
a single class of low affinity receptors with a Km of approxi-
mately 14 m (Fig. 3).
Previous studies from our laboratory revealed that mesangial
cells grown in medium containing 30 m glucose synthesized
and accumulated increased amounts of fibronectin, laminin, and
type IV collagen (Fig. 4)111, 12]. ECM protein degradation was
unaffected. mRNA levels for all three matrix proteins were
elevated after three days exposure to medium containing 30 mM
glucose (Fig. 5) [121. Total protein synthesis and actin mRNA
levels were unaltered by growth in 30 m glucose. Exposure to
high glucose medium resulted in a threefold increase in DAG
mass within 30 minutes which remained elevated through one
week of exposure to high glucose (Table 2) [13]. Glucose may
affect DAG levels through receptor mediated phosphoinositide
hydrolysis or by increasing the de novo synthesis of DAG [18,
19]. We found previously that phosphoinositide hydrolysis was
Condition Duration DAG massa
10 m glucose 162.5 65
30 m glucose 30 mm 444 32
30 m glucose 24 hr 674 50
30 m glucose 1 week 467 78
unaffected by high glucose, implying that DAG was derived
through increased de novo synthesis [13]. After 60 minutes of
exposure to 30 mM glucose, there was translocation of protein
kinase C from the cytosolic to particulate cellular fraction [13]
(indicative of activation) [18—20]. Thus, glucose may be exerting
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Fig. 3. Double reciprocal plot of3H-2-deoxyglucose uptake data, Data
indicate a single class of low affinity receptors with an apparent Km of
14 mM.
Table 2. Effect of glucose on DAG mass
pmols/l03 cells; DAG mass was measured from the quantitative
conversion of DAG to 32PI phosphatidic acid as described by Preiss et
al [34.
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Fig. 4. Immunoperoxidase staining for fibronectin (A, B), laminin (C, D) and type IV collagen (E, F) from mesangial cells grown for 4 weeks
without passaging in JO m glucose (A,C,E) or 30 m glucose (B,D,F). Note the fibrillar staining pattern and that the degree of staining is greater
in the hillocks (arrows). Also note that the fibrillar staining pattern is similar in the cells grown in 10 m and 30 m glucose but the staining intensity
is much greater (x50). (Fig. 4 is from Ayo et al: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am
J Pathol 136:1339—1348, 1990, used with permission.)
its effect on mesangial cell ECM synthesis by activating protein
kinase C. To determine whether protein kinase C activation
increases ECM levels, mesangial cells were treated overnight
with OAG and PMA to activate protein kinase C, and total
RNA was extracted and probed with cDNAs to fibronectin,
laminin and type IV collagen [131. Activation of protein kinase
C resulted in increased expression of mRNA for all three matrix
proteins; actin mRNA was unaltered [13].
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Discussion
Thickening of capillary basement membranes is the major
structural abnormality encountered in diabetes mellitus. It is
most evident in capillaries of the skin, skeletal muscles, retina,
renal glomeruli, and renal medulla, giving rise to the character-
istic diabetic microangiopathy of these organs [211. Diabetic
glomerulosclerosis, which is characterized by expansion of the
glomerular mesangium which eventually progresses to obliter-
ate the capillary lumina, is a leading cause of morbidity and
mortality in diabetes. Although hyperglycemia is clearly in-
volved with development of diabetic complications, the mech-
anisms by which glucose exerts its adverse effects are un-
known. Both endothelial cells and glomerular mesangial cells in
culture show increased synthesis of ECM proteins and mRNA
when grown in medium containing high glucose [11, 12, 22].
Therefore, such a model is useful to elucidate the mechanisms
by which glucose exerts its effect on ECM metabolism.
Mesangial cells, like other cells that are susceptable to injury
induced by the diabetic state (that is, eyes, nerves and vascu-
lature), transports glucose by an insulin insensitive, facilitative-
diffusion type of glucose transport [23—25]. From our studies, it
might be expected that the intracellular glucose concentrations
in mesangial cells would reach the levels achieved in diabetes.
Mesangial cells as well as other types of cells which display a
facilitative diffusion transport system for glucose contain aldose
reductase activity (that is, the polyol pathway) and severalfold
increases in the intracellular levels of sorbitol occur following
incubation in high glucose [25—28]. Sorbitol accumulation can
cause osmotic swelling of cells and result in disturbed cellular
7.9 Kb
6.8 Kb
Fig. 5. Effect of high glucose on fibronectin,
laminin, al type (IV)-collagen and /3-actin
mRNA levels. Cells were grown for I to 4
days in medium containing 10 or 30 mM
glucose. Same Northern blot of total RNA (30
g/1ane) was hybridized to a labeled cDNA,
stripped of that probe, and rehybridized to
U.U another labeled eDNA. Sizes in kilobases (kb)
of mRNAs are indicated as deduced from
comparison of RNA molecular markers
(Boehringer Mannheim Biochemicals,
Indianapolis, Indiana, USA). Control cells (C)
grown 4 days in medium containing 10 mr'i
glucose; 1,2,3, and 4 days of growth in
medium containing 30 m glucose. (From
Ayo et a!: Increased extracellular matrix
2.2 Kb synthesis and mRNA in mesangial cells grown
in high-glucose medium. Am J Physiol 260:
Fl85—F191, 1991; used with permission.)
functions (such as increased cell turnover and ECM accumula-
tion). In addition, polyol accumulation has been associated with
depletion of cellular myoinositol leading to alterations in cell
growth and survival [29]. Our studies show that mesangial cells
treated with high glucose do not display alterations in growth,
nor do they display alterations in vasopressin stimulated phos-
phoinositide hydrolysis [13].
Retinal capillary endothelial cells treated with high glucose
accumulate sorbitol; however, the inositol phospholipids are
unaltered and protein kinase C is activated [18, 30]. Similar
activation of protein kinase C has been reported in glomeruli
isolated from streptozotocin diabetic rats despite a reduction in
inositol content and polyphosphoinositide turnover [31]. Gb-
meruli from normal rats display activation of protein kinase C
when incubated with increasing concentrations of glucose [31].
In addition to phosphoinositide hydrolysis, DAG can be syn-
thesized de novo from the glycolytic intermediates dihydroxy-
acetone phosphate and glycerol 3-phosphate by means of a
stepwise acylation. Such a mechanism has been shown to be
operative in cultures of retinal capillary endothelial cells [18]
and isolated glomeruli [19] treated with high glucose. Activation
of the polyol pathway in high glucose states may provide
nicotinamide adenine dinucleotide (the reduced form) for DAG
synthesis [32]. This increase in DAG results in the transbocation
of protein kinase C from the cytosol to the particulate cellular
fraction, indicative of activation.
Protein kinase C was identified as a proteolytically activated
protein kinase and is now known to be ubiquitous in tissues and
organs [14—16]. Protein kinase C activation is involved with
u (IV) collagen
B1 laminin
actin
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transducing extracellular signals received from growth factors,
hormones and, perhaps, as suggested by our studies, high
glucose into a physiological response. The role protein kinase C
plays in cell activation can be confirmed by activating the
enzyme with PMA or OAG. Recently, it has been reported that
concentrations of PMA and OAG which activated protein
kinase C resulted in increased expression of ECM mRNAs [131.
Thus, protein kinase C may play an important role in the
developing microangiopathy seen in diabetes by phosphorylat-
ing protein(s) involved in ECM gene expression. In this regard,
it has been reported that the protein kinase C activity associated
with proximal tubule brush border membranes isolated from
diabetic rats increases dramatically and may be responsible for
the observed renal hypertrophy [33].
Acknowledgments
This work was supported by NIH PHS grant DK 29787 and a grant
from the National Kidney Foundation (SHA). Dr. Kreisberg is a
recipient of a Career Scientist Award from the Department of Veteran's
Affairs.
Reprint requests to Jeffrey I. Kreisberg, Ph.D., Department of
Pathology, U.T.H.S.C.S.A., 7703 Floyd Curl Drive, San Antonio,
Texas 78284-7750, USA.
References
1. MAUER SM, BARBOSA MJ, VERNIER RL, KJELLSTRAND CM,
BUSELMEIER TJ, SIMMONS RL, NAJARIAN JS, GOETZ FC: Devel-
opment of diabetic vascular lesions in normal kidneys transplanted
into patients with diabetes mellitus. N Engl J Med 295:916—926,
1976
2. WILLIAMSON JR, KILO C: Vascular complications in diabetes
mellitus. N Engi J Med 302:399—400, 1980
3. KiLo C: Value of glucose control in preventing complications of
diabetes. Am J Med 79:33—37, 1959
4. Bn.ous RW, MAUER SM, SUTHERLAND DER, NAJARIAN JS,
GOETZ FC, STEFFES MW: The effects of pancreas transplantation
on the glomerular structure of renal allografts in patients with
insulin-dependent diabetes. N Engi J Med 321:80—85, 1989
5. STEFFES MW, BROWN DM, BASGEN JM, MAUER SM: Ameliora-
tion of mesangial volume and surface alterations following islet
transplantation in diabetic rats. Diabetes 29:509—5 15, 1980
6. IIDAKA K, McCoy J, KIMMSELSTEIL P: The glomerular me-
sangium. A quantitative analysis. Lab Invest 19:573—579, 1968
7. KAWANO E, ARAKAWA M, McCoy i, PERCH J, KIMMSELSTEIL P:
Quantitative study of glomeruli. Focal glomerunephritis and dia-
betic glomerulosclerosis. Lab Invest 21:269—275, 1969
8. ABRASS CK, PETERSON CV, RANG! GJ: Phenotypic expression of
collagen types in mesangial matrix of diabetic and nondiabetic rats.
Diabetes 37:1695—1702, 1988
9. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER,
BROWN DM, GOETZ FC: Structural functional relationships in
diabetic nephropathy. J Clin Invest 97:1143—1155, 1984
10. STEFFES MW, OSTERBY R, CHAVERS B, MAUER SM: Mesangial
expansion as a central mechanism for loss of kidney function in
diabetic patients. Diabetes 38:1077—1081, 1989
11. A'o SH, RADNIK RA, GARONI J, GLASS WF II, KREISBERG JI:
High glucose causes an increase in extracellular matrix proteins in
cultured mesangial cells. Am JPathol 136:1339—1348, 1990
12. Avo SH, RADNIK RA, GLASS WF II, GARONI J, RAMPT ER,
APPLING DR, KREISBERG JI: Increased extracellular matrix synthe-
sis and mRNA in mesangial cells grown in high-glucose medium.
Am J Physiol 260:F185—Fl91, 1991
13. AY0 SH, RADNIK R, GARONI J, TROYER RA, KREISBERG JI: High
gluocse increases diacylglycerol mass and activates protein kinase
C in mesangial cell cultures. Am J Physiol 261:F571—F577, 1991
14. BELL RM: Protein kinase C activation by diacylglycerol second
messengers. Cell 45:631—632, 1986
15. BERRIDGE MJ: Growth factors, oncogenes and inositol phospholip-
ids. Cancer Surveys 5:413—430, 1986
16. NISHIZUKA Y: Studies and perspectives of protein kinase C.
Science 233:305—312, 1986
17. VENKATACHALAM MA, KREISBERG JI: Agonist-induced isotonic
contraction of cultured mesangial cells after multiple passage. Am J
Physiol 249:C48—C55, 1985
18. LEE TS, SALTSMAN KA, OHASHI H, KING GL: Activation of
protein kinase C by elevation of glucose concentration: Proposal
for a mechanism in the development of diabetic vascular complica-
tions. Proc Nat! Acad Sci USA 86:5141—5145, 1989
19. CRAVEN PA DAVIDSON DM, DERUBERTIS FR: Increase in diacyl-
glycerol mass in isolated glomeruli by glucose from de novo
synthesis of glycerolipids. Diabetes 39:667—674, 1990
20. THOMAS PT, GEPALAKRISHNA R, ANDERSON WB: Hormone- and
tumor promoter-induced activation or membrane association of
protein kinase C in intact cells, in Methods in Enzymology, edited
by MEANS AR, CONN PM, New York, Academic Press, 1987, pp.
399—412
21. COTRAN RS, KUMAR V, R0BBINs SL: Robbins Pathologic Basis of
Disease (4th ed). Philadelphia, W.B. Saunders Co., pp. 994—1005
22. CAGLIERO E, MAIELLO M, BOERI D, ROY S, LORENZI M: Increased
expression of basement membrane component in human endothe-
hal cells cultured in high glucose. J Clin invest 82:735—738, 1988
23. CORKEY RF, CORKEY BE, GIMBRONE MA: Hexose transport in
normal and SV4O-transformed human endothelial cells in culture. J
Cell Physiol 106:425 —434, 1981
24. BETZ AL, BOWMAN PD, GOLDSTEIN GW: Hexose transport in
microvascular endothelial cells cultured from bovine retina. Eye
Res 36:269—277, 1983
25. CLEMENTS RS: Diabetic Neuropathy—new concepts of its etiol-
ogy. Diabetes 28:604—611, 1979
26. CORKEY RF, CORKEY BE, GIMBRONE MA: Hexose transport and
sorbitol accumulation in cultured human endothelial cells. (ab-
stract) Diabetes 27:446, 1978
27. BEYER-MEARS A, Ku L, COHEN MP: Glomerular polyol accumu-
lation in diabetes and its prevention by oral sorbinil. Diabetes
33:604—607, 1984
28. HANEDA M, KIKKAWA R, ARIMURA T, EBATA K, TOGAWA M,
MAEDA S, SAWADA T, HORIDE N, SHIGETA Y: Glucose inhibits
myo-inositol and reduces myo-inositol content in cultured rat
glomerular mesangial cells. Metabolism 39:40—45, 1990
29. LORENZI M, CAGLIERO E, TOLEDO S: Glucose toxicity for human
endothelial cells in culture: Delayed replication, disturbed cell
cycle, and accelerated death. Diabetes 34:621—627, 1985
30. LEE TS, MACGREGOR JJ, FLUHARTY JJ, KING OL: Differential
regulation of protein kinase C and (Na,K)-adenosine triphosphatase
activities by elevated glucose levels in retinal capillary endothelial
cells. J Clin Invest 83:90—94, 1989
31. CRAVEN PA, DERUBERTIS FR: Protein kinase C is activated in
glomeruli from streptozotocin diabetic rats. Possible mediation by
glucose. J Clin Invest 83:1667—1675, 1989
32. WOLF BA, WILLIAMSON JR, EASOM RA, CHANG K, SHERMAN
WR, TURK J: Diacylglycerol accumulation and microvascular ab-
normalities induced by elevated glucose levels. J Clin invest
87:31—38, 1991
33. HISE MK, MEHTA PS: Characterization and localization of calcium/
phospholipid-dependent protein kinase C during diabetic renal
growth. Endocrinology 123:1553—1558, 1988
34. PREIsS J, LOOMIS CR, BISHOP WR, STEIN R, NIEDEL JE, BELL
RM: Quantitative measurement of sn-i ,2-diacylglycerols present in
platelets, hepatocytes, and ras- and cis-transformed normal rat
kidney cells. J Biol Chem 261:8597—8600, 1986
